Xiwu Ouyang

No. 87, Xiangya Road
Changsha, 410008, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 19 publications

TIMP1 and DPP4 Promote Tumor Progression by Regulating Lactate Metabolism in Papillary Thyroid Carcinoma.

TIMP1 and DPP4 Promote Tumor Progression by Regulating Lactate Metabolism in Papillary Thyroid Carcinoma.

Journal: Cancers

Published: March 12, 2026

Adipocyte promotes tumor cell invasion and metastasis via FATP2: a novel cell-cell interaction in papillary thyroid carcinoma.

Adipocyte promotes tumor cell invasion and metastasis via FATP2: a novel cell-cell interaction in papillary thyroid carcinoma.

Journal: Gland surgery

Published: October 28, 2025

Single status shows age dependent bidirectional effects in differentiated thyroid cancer.

Single status shows age dependent bidirectional effects in differentiated thyroid cancer.

Journal: Scientific reports

Published: June 16, 2025

RNF2 inhibits E-Cadherin transcription to promote hepatocellular carcinoma metastasis via inducing histone mono-ubiquitination.

RNF2 inhibits E-Cadherin transcription to promote hepatocellular carcinoma metastasis via inducing histone mono-ubiquitination.

Journal: Cell death & disease

Published: November 30, 2022

Mechanism of Liver Regeneration During ALPPS.

Mechanism of Liver Regeneration During ALPPS.

Journal: Frontiers in cell and developmental biology

Published: April 09, 2022

MAD2L1 Functions As a Novel Diagnostic and Predictive Biomarker in Cholangiocarcinoma.

MAD2L1 Functions As a Novel Diagnostic and Predictive Biomarker in Cholangiocarcinoma.

Journal: Genetic testing and molecular biomarkers

Published: November 17, 2021

E2F3 promotes liver cancer progression under the regulation of circ-PRKAR1B.

E2F3 promotes liver cancer progression under the regulation of circ-PRKAR1B.

Journal: Molecular therapy. Nucleic acids

Published: April 13, 2021

Loss of ARID1A Promotes Hepatocellular Carcinoma Progression via Up-regulation of MYC Transcription.

Loss of ARID1A Promotes Hepatocellular Carcinoma Progression via Up-regulation of MYC Transcription.

Journal: Journal of clinical and translational hepatology

Published: March 25, 2021

Loss of androgen receptor promotes HCC invasion and metastasis via activating circ-LNPEP/miR-532-3p/RAB9A signal under hypoxia.

Loss of androgen receptor promotes HCC invasion and metastasis via activating circ-LNPEP/miR-532-3p/RAB9A signal under hypoxia.

Journal: Biochemical and biophysical research communications

Published: February 20, 2021

R-2HG downregulates ERα to inhibit cholangiocarcinoma via the FTO/m6A-methylated ERα/miR16-5p/YAP1 signal pathway.

R-2HG downregulates ERα to inhibit cholangiocarcinoma via the FTO/m6A-methylated ERα/miR16-5p/YAP1 signal pathway.

Journal: Molecular therapy oncolytics

Published: September 22, 2020

Testicular orphan receptor 4 (TR4) promotes papillary thyroid cancer invasion via activating circ-FNLA/miR-149-5p/MMP9 signaling.

Testicular orphan receptor 4 (TR4) promotes papillary thyroid cancer invasion via activating circ-FNLA/miR-149-5p/MMP9 signaling.

Journal: Molecular therapy. Nucleic acids

Published: July 24, 2020

Androgen receptor (AR) decreases HCC cells migration and invasion via miR-325/ACP5 signaling.

Androgen receptor (AR) decreases HCC cells migration and invasion via miR-325/ACP5 signaling.

Journal: Journal of Cancer

Published: June 07, 2020

Showing 1-12 of 19

Last Updated: 09/26/2026